Cargando…
LigBuilder V3: A Multi-Target de novo Drug Design Approach
With the rapid development of systems-based pharmacology and poly-pharmacology, method development for rational design of multi-target drugs has becoming urgent. In this paper, we present the first de novo multi-target drug design program LigBuilder V3, which can be used to design ligands to target...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059350/ https://www.ncbi.nlm.nih.gov/pubmed/32181242 http://dx.doi.org/10.3389/fchem.2020.00142 |